How is Hepatitis C Treatment Changing?

Here, UCSF's Annie Luetkemeyer talks about new treatments for hepatitis C and what they will do for people with infections.

Here, UCSF's Annie Luetkemeyer talks about new treatments for hepatitis C and what they will do for people with infections.

Related Content:

InterviewsHepatitisSpecialty Pharmacy
Study Shows Higher BTKi-Related Toxicity Burden with Ibrutinib, Lower Impact of CV-Related Toxicity with Acalabrutinib
Facilitating Access to Oncology Medication
Zanubrutinib, Venetoclax Combination Therapy Well-Tolerated in Certain Patients With CLL or SLL